Beacon Pointe Advisors, LLC Abbott Laboratories Transaction History

Beacon Pointe Advisors, LLC

$8.35 Billion
Q2 2024

A detailed history of Beacon Pointe Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 213,687 shares of ABT stock, worth $24 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

213,687

Previous 231,940 7.87%

Holding current value

$24 Million

Previous $26.4 Million 15.77%

% of portfolio

0.27%

Previous 0.3%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $1.84 Million - $2.05 Million	-18,253 Reduced 7.87%	213,687 $22.2 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $6.88 Million - $7.59 Million	-62,789 Reduced 21.3%	231,940 $26.4 Million
Q4 2023 Feb 08, 2024	BUY	$90.19 - $110.4 $2.57 Million - $3.14 Million	28,443 Added 10.68%	294,729 $32.4 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $8.56 Million - $10.3 Million	89,570 Added 50.69%	266,286 $25.8 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $3.1 Million - $3.45 Million	-30,739 Reduced 14.82%	176,716 $19.3 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $3.09 Million - $3.64 Million	31,936 Added 18.2%	207,455 $21 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $661,427 - $775,956	-6,958 Reduced 3.81%	175,519 $19.3 Million
Q3 2022 Nov 09, 2022	SELL	$96.76 - $112.03 $276,056 - $319,621	-2,853 Reduced 1.54%	182,477 $17.7 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $4.13 Million - $5 Million	-40,497 Reduced 17.93%	185,330 $20.1 Million
Q1 2022 May 17, 2022	BUY	$114.02 - $139.04 $20.7 Million - $25.2 Million	181,356 Added 407.81%	225,827 $26.7 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $14.2 Million - $17.4 Million	-122,928 Reduced 73.43%	44,471 $6.26 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $15.5 Million - $17.1 Million	132,653 Added 381.78%	167,399 $19.8 Million
Q2 2021 Aug 17, 2021	BUY	$105.79 - $124.53 $1.98 Million - $2.33 Million	18,703 Added 116.58%	34,746 $4.03 Million
Q1 2021 May 18, 2021	BUY	$108.84 - $128.23 $178,062 - $209,784	1,636 Added 11.36%	16,043 $1.92 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $167,685 - $182,728	1,597 Added 12.47%	14,407 $1.58 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $85,500 - $103,833	933 Added 7.86%	12,810 $1.4 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $522,666 - $668,948	6,826 Added 135.14%	11,877 $1.09 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $113,767 - $166,358	1,811 Added 55.9%	5,051 $398,000
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $66,419 - $73,940	846 Added 35.34%	3,240 $282,000
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $195,924 - $212,443	2,394 New	2,394 $200,000
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $188,613 - $219,980	-2,588 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $171,377 - $207,195	2,588 New	2,588 $206,000

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.

Account

Beacon Pointe Advisors, LLC Abbott Laboratories Transaction History